Browse the corpus

REFERENCES Buitelaar JK, van der Gaag RJ, and van der Hoeven J, “Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study,” J Clin Psychiatry , 1998, 59(2):56-9. Carrey NJ, Wiggins DM, and Milin RP, “Pharmacological Treatment of Psychiatric Disorders in Children and Adolescents,” Drugs , 1996, 51(5):750-9. Fanciullacci M, Sicuteri R, Alessandri M, et al, “Buspirone, But Not Sumatriptan, Induces Miosis in Humans: Relevance for a Serotoninergic Pupil Control,” Clin Pharmacol Ther , 1995, 57(3):349-55. Gammans RE, Mayol RF, and LaBudde JA, “Metabolism and Disposition of Buspirone,” Am J Med , 1986, 80(3B):41-51. [PubMed 3515929 ] Gammans RE, Westrick ML, Shea JP, et al, “Pharmacokinetics of Buspirone in Elderly Subjects,” J Clin Pharmacol , 1989, 29(1):72-8. Goetz CM, Krenzelok EP, Lopez G, et al, “Buspirone Toxicity: A Prospective Study,” Vet Hum Toxicol , 1989, 31:371. Green WH, Child and Adolescent Clinical Psychopharmacology , 3rd ed, Philadelphia, PA: Lippincott Williams & Wilkins, 2001. Hanna GL, Feibusch EL, and Albright KJ, “Buspirone Treatment of Anxiety, Associated With Pharyngeal Dysphagia in a Four-Year Old,” J Child Adolesc Psychopharmacol , 1997, 7(2):137-43. Jann MW, “Buspirone: An Update on a Unique Anxiolytic Agent,” Pharmacotherapy , 1988, 8(2):100-16. [PubMed 3041384 ] Kivisto KT, Lamberg TS, and Kantola T, “Plasma Buspirone Concentrations Are Greatly Increased by Erythromycin and Itraconazole,” Clin Pharmacol Ther , 1997, 62(3):348-54. Kunik ME, Yudofsky SC, Silver JM, et al, “Pharmacologic Approach to Management of Agitation Associated With Dementia,” J Clin Psychiatry , 1994, 55(Suppl 2):13-7. Kutcher SP, Reiter S, Gardner DM, et al, “The Pharmacotherapy of Anxiety Disorders in Children and Adolescents,” Psychiatr Clin North Am , 1992, 15(1):41-67. Lejoyeux M, et al, “Serotonin Syndrome: Incidence, Symptoms, and Treatment,” CNS Drugs , 1994, 2:132-43. McIvor RJ and Sinanan K, “Buspirone-Induced Mania,” Br J Psychiatry , 1991, 158:136-7. Norden MJ, “Buspirone Treatment of Sexual Dysfunction Associated With Selective Serotonin Reuptake Inhibitors,” Depression , 1994, 2:109-12. Pfeffer CR, Jiang H, and Domeshek LJ, “Buspirone Treatment of Psychiatrically Hospitalized Prepubertal Children With Symptoms of Anxiety and Moderately Severe Aggression,” J Child Adolesc Psychopharmacol , 1997, 7(3):145-55.

Norden MJ, “Buspirone Treatment of Sexual Dysfunction Associated With Selective Serotonin Reuptake Inhibitors,” Depression , 1994, 2:109-12. Pfeffer CR, Jiang H, and Domeshek LJ, “Buspirone Treatment of Psychiatrically Hospitalized Prepubertal Children With Symptoms of Anxiety and Moderately Severe Aggression,” J Child Adolesc Psychopharmacol , 1997, 7(3):145-55. Preskorn SH, “Recent Pharmacologic Advances in Antidepressant Therapy for the Elderly,” Am J Med , 1993, 94(5A):2S-12S. Schweizer E and Rickels K, “New and Emerging Clinical Uses for Buspirone,” J Clin Psychiatry Monograph , 1994, 12(1):46-54. Simeon JG, Knott VJ, DuBois C, et al, “Buspirone Therapy of Mixed Anxiety Disorders in Childhood and Adolescence: A Pilot Study,” J Child Adolesc Psychopharmacol , 1994, 4(3):159-70. Soni P and Weintraub AL, “Buspirone-Associated Mental Status Changes,” J Am Acad Child Adolesc Psychiatry , 1992, 31(6):1098-9. Sussman N, “The Usage of Buspirone in Psychiatry,” J Clin Psychiatry Monograph , 1994, 12(1):3-19. Tiller JW, Burrows GD, and O'Sullivan BT, “Buspirone Overdose,” Med J Aust , 1989, 150(1):54-5. Weis KJ, “Management of Anxiety and Depression Syndromes in Elderly,” J Clin Psychiatry , 1994, 55(Suppl 2):5-12. Topic 9172 Version 46.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-122.72.76.133-8539BEA455-S244013.14]